Dec. 3 at 1:22 AM
$ABT Abbott Laboratories delivers an impressive 21% EPS growth over the last three years, reinforcing NYSE:ABT as one of the strongest healthcare stocks to buy. Discover how Abbott’s
$44B revenue base and global medical device dominance fuel long-term upside. https://biotechhealthx.com/biotech-news/abbott-laboratories-abt-posts-stunning-21-eps-growth-is-this-the-strongest-healthcare-stock-of-2025/